Table 2.
Cost components from studies based on data from provider/system perspective
| Country/study | Diabetes type | Outpatient (per visit) | Cost components, average per person (2016 US$) | ||||
| Outpatient visits (per year) |
Laboratory (per year) | Medicines (per year) | Inpatient (per year) | ||||
| LMICs (n=1) | Bangladesh40 | 2 | * | 24.00 | 27.00 | 194.00 | |
| UMICs (n=10) | Iran41 | 2 | * | * | 4.72 | * | * |
| Thailand42 | 1 and 2 | 3.99 | 18.09 | 14.74 | 26.41 | 24.95 | |
| China43 | 1 and 2 | * | * | * | * | 990.79 | |
| China44 | * | * | * | * | 1790.22 | ||
| Mexico45 | 2 | 10.75 | 84.81 | * | 73.07 | * | |
| Mexico46 | 2 | 42.32 | 173.29 | 24.13 | * | * | |
| Brazil47 | 2 | 4.75 | 8.66 | 16.16 | 91.30 | * | |
| Brazil48 | 1 | * | * | 56.93 | 415.47 | 29.44 | |
| Turkey49 | 2 | * | * | * | 668.41 | * | |
| Argentina50 | 1 and 2 | 21.74 | 152.43 | 40.06 | 679.60 | ||
*Authors did not provide data on this cost component.
LMIC, lower middle-income country; UMIC, upper middle-income country.